Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
about
FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chanceClinical characteristics in Taiwanese women with polycystic ovary syndromeObesity and PCOS: implications for diagnosis and treatmentCoffin–Siris Syndrome with obesity, macrocephaly, hepatomegaly and hyperinsulinism caused by a mutation in the ARID1B geneResearching Effective Strategies to Improve Insulin Sensitivity in Children and Teenagers - RESIST. A randomised control trial investigating the effects of two different diets on insulin sensitivity in young people with insulin resistance and/or prePharmacotherapy of polycystic ovary syndrome--an update.Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndromePrevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary SyndromeInsulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.Comparison of highly purified urinary versus recombinant FSH: Effect on ART outcomes in polycystic ovary syndrome.Effects of metformin use in pregnant patients with polycystic ovary syndrome.Sexual Functioning among Married Iranian Women with Polycystic Ovary SyndromePolycystic ovary syndrome in women using valproate: a review.The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials.Polycystic ovary syndrome in the pediatric populationState of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study.The role of vitamin D in reproductive health--a Trojan Horse or the Golden Fleece?Phenotype and metabolic disorders in polycystic ovary syndrome.Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model.Effect of metformin on serum ferritin level in women with polycystic ovary syndromeCardiometabolic aspects of the polycystic ovary syndrome.Predictors of insulin resistance and metabolic complications in polycystic ovarian syndrome in an eastern Indian population.Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?Polycystic ovary syndrome and oocyte developmental competence.Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Association between circulating adiponectin levels and polycystic ovarian syndrome.The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trialEvaluation of reproductive function in women treated for bipolar disorder compared to healthy controls.Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary SyndromeEffects of polycystic ovary syndrome on health-related quality of life.Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.Polycystic ovary syndrome and insulin: our understanding in the past, present and future.Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children.Expression and regulation of INTELECTIN1 in human granulosa-lutein cells: role in IGF-1-induced steroidogenesis through NAMPT.The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?Polycystic ovary syndrome, adipose tissue and metabolic syndrome.Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with polycystic ovary syndrome: a meta-analysis.
P2860
Q21135603-A345AEAB-47E7-44C1-B34A-110D4D8B7427Q26782559-1E2B8F03-4C63-4C93-8634-06E40B11416FQ27000954-F8EF616E-0177-4280-B71B-48499D6B6925Q29037119-B34AB8F8-18E6-44DB-AC3E-F50E4F35629EQ33702784-162D4421-E253-40CF-B36F-1171D171C2E3Q33787190-CDDB948C-634B-42F1-BAA6-6C99CC8A5FFAQ33948903-1842DDBC-8FCF-475B-95DE-34204AD72753Q34019107-B599C0BD-1D1D-4F8B-B8DD-44FE22A827D8Q34137763-77E540EB-25BB-433B-A060-5BAF0F90C847Q34196656-665ADCB1-7E09-4639-A16C-C19C2B0D4467Q34312544-A3E2BA60-7345-471E-8C0B-8732F43623A7Q34458922-756AB618-0006-4D28-872D-50DA9E693640Q34881401-812DAD18-F761-417F-A4AA-01B06F927B46Q34983821-117E88FA-411A-480A-8852-1A2AD9790C60Q35015466-9BEEFF64-6794-40A6-A66F-04ECCACC3DAAQ35075035-41E92B5B-B612-463B-A37D-745D691422BDQ35233754-6DD53F95-820E-4A5D-B4BD-4D712EA1CE62Q35544333-F2847F61-8748-4481-B27D-63F1F0645402Q35808839-CAD51CF9-2B5E-450F-B133-8436F9F68B47Q35825445-C280B97E-1CF3-4AE7-93B3-4B4EBD3180A4Q35890067-471656EA-EDC3-4604-B723-2C81691EB422Q36022491-1040DB0B-2125-474C-BA6B-839D459D9C9CQ36287892-6C3CF8A5-97C4-4AF4-82E8-0CB688B0E58CQ36732197-84A831C8-5CB7-4544-AEE5-2116E663A95AQ36759686-FA9118D9-58FE-4ABF-9353-9DE542B4631BQ37032912-4CB0EEA9-5FE3-4DBD-9EFD-F23625D1490EQ37071255-D4C14C81-0990-4E73-8349-3D3144F0C2CBQ37412812-F69E140F-E77B-42D0-868E-679D9523E5BCQ37591691-2AA31B89-FF11-47E0-977A-7DCAC8BC2E88Q37615439-4F75E079-B96F-44C1-A597-34BC377D9A34Q37625064-40FD8427-4C61-4016-AF4C-7E19AA08194CQ37675441-C8565304-50D7-4F76-BF03-7288701990B3Q37763118-A4FA44D1-794A-426D-A73E-E763F5CAA05EQ38102595-F213C0D0-CDF6-498C-9C1E-4D07AFC1D293Q38380065-41EC9F57-F881-4DF1-9463-3EFE9D58500DQ38383203-4930B6DF-A728-4A32-962A-AD00F3F97C5BQ38983232-B6A89BE1-BB48-4758-A21C-98EED5D80062Q39001136-C4648101-59AE-4018-A8C3-7F784F20A8FDQ39393050-3A81FED6-9991-4C55-ABEB-B007BB808414Q39586744-2DE68A0C-6C3B-4035-A510-88337E854C58
P2860
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Controversy in clinical endocr ...... terdam criteria are premature.
@ast
Controversy in clinical endocr ...... terdam criteria are premature.
@en
Controversy in clinical endocr ...... terdam criteria are premature.
@nl
type
label
Controversy in clinical endocr ...... terdam criteria are premature.
@ast
Controversy in clinical endocr ...... terdam criteria are premature.
@en
Controversy in clinical endocr ...... terdam criteria are premature.
@nl
prefLabel
Controversy in clinical endocr ...... terdam criteria are premature.
@ast
Controversy in clinical endocr ...... terdam criteria are premature.
@en
Controversy in clinical endocr ...... terdam criteria are premature.
@nl
P356
P1476
Controversy in clinical endocr ...... terdam criteria are premature.
@en
P304
P356
10.1210/JC.2005-2153
P407
P577
2006-01-17T00:00:00Z